Journal
EPIGENOMICS
Volume 11, Issue 1, Pages 35-51Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/epi-2018-0123
Keywords
chemotherapy resistance; diffuse large B-cell lymphoma; exosomes; miRNA
Categories
Funding
- National Natural Science Foundation of China [81570200]
Ask authors/readers for more resources
Aim: To analyze the expression profiles, clinicopathological features and chemotherapeutic efficacies of exosome-derived miRNAs in diffuse large B-cell lymphoma (DLBCL). Materials & methods: Next-generation sequencing technique was performed to identify miRNA profiles in exosomes from parental and chemoresistant DLBCL cells. The results were validated by quantitative real-time PCR, and further analyzed by bioinformatics and statistical methods. Results: We identified 37 significantly upregulated and 17 downregulated miRNAs. Of four upregulated miRNAs validated, we found miR-99a-5p and miR-125b-5p were significantly upregulated. Increased levels of exosomal miR-99a-5p and miR-125b-5p in DLBCL patients' serum were associated with shorter progression-free survival time, and they can predict chemotherapeutic efficacy. Conclusion: Exosomal miR-99a-5p and miR-125b-5p can serve as biomarkers for DLBCL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available